Correspondence to letter to the editor on "Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study"

Young Eun Chon; Dong Yun Kim; Hong Jae Chon; Do Young Kim

doi:10.3350/cmh.2024.0916

YUHSpace

BROWSE

9 11

Cited 0 times in

Correspondence to letter to the editor on "Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study"

Authors: Young Eun Chon ; Dong Yun Kim ; Hong Jae Chon ; Do Young Kim

Citation: CLINICAL AND MOLECULAR HEPATOLOGY, Vol.31(1) : e98-e100, 2025-01

Journal Title: CLINICAL AND MOLECULAR HEPATOLOGY

ISSN: 2287-2728

Issue Date: 2025-01

Keywords: Hepatocellular carcinoma ; Lenvatinib ; Sorafenib

Files in This Item:: T202504060.pdf Download

DOI: 10.3350/cmh.2024.0916

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

Yonsei Authors: Kim, Do Young(김도영)

URI: https://ir.ymlib.yonsei.ac.kr/handle/22282913/206274

사서에게 알리기

Show full item record Find it @ YMLIB

License

YUHSpace: Correspondence to letter to the editor on "Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study"

YUHSpace

BROWSE

Browse

Links